Decision Diagnostics in Receipt of Revised Cash Offer from Proposed M&A Partner, Enhanced by 21% Over Previously Disclosed Proposals
LOS ANGELES, CA / ACCESSWIRE / September 7, 2017 / Decision Diagnostics Corp. (OTC PINK: DECN) is the FDA registered manufacturer, quality plan administrator, medical device customer support, and exclusive worldwide sales service and regulatory process agent for the GenUltimate! test strip and the new GenSure! test strip used in the testing of blood sugar to detect diabetes and pre-diabetes. DECN is also in advanced development of its GenChoice!...
Read more








